Drug for preventing/treating ocular disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9555028
APP PUB NO 20150148350A1
SERIAL NO

14413455

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a medicament for preventing or treating an ocular disease comprising cyclo-trans-4-L-hydroxyprolyl-L-serine as an active ingredient, a medicament for preventing or treating dry eye comprising the compound as an active ingredient, and, in particular, a medicament for preventing or treating dry eye having an action of enhancing mucin secretion and an action of enhancing repair of ocular tissue damage caused by dry eye.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JAPAN BIO PRODUCTS CO LTD1-44-4 TOMIGAYA SHIBUYA-KU TOKYO 151-0063
THE DOSHISA601 GEMBU-CHO KARASUMA-HIGASHI-IRU IMADEGAWA-DORI KAMIGYO-KU KYOTO-SHI KYOTO 602-8580

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akitsu, Masashi Tokyo, JP 1 0
Kadota, Yoshiharu Osaka, JP 3 2
Kaku, Taiichi Tokyo, JP 5 3
Nakamura, Takahiro Kyotanabe, JP 195 3533
Yamaguchi, Shumpei Tokyo, JP 6 90

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 31, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00